6 stocks are in the top 100 in trading volume… Daewon Pharmaceutical is ranked 28th with 98.29 million shares
In August, pharmaceutical stocks regained vitality and entered the top ranks in trading volume and value.
In particular, 10 out of 45 components of the pharmaceutical industry index ranked in the top 100 among more than 900 listed stocks on Korea Stock Exchange (KSE).
Among them, SK Bioscience, which had the highest stock price increase among listed stocks in KSE in August, recorded KRW 22.2866 trillion in trading value for a month, ranking in second place.
Celltrion ranked 9th with KRW 4.851 trillion in trading value, Shinpoong Pharmaceutical 11th with KRW 3.61 trillion, and Samsung Biologics 12th with KRW 3.4274 trillion.
GeneOne Life Science ranked 25th with KRW 2.28 trillion, Daewon Pharmaceutical 27th with KRW 2.675 trillion, Reyon Pharmaceutical 29th with KRW 1.8482 trillion, and Bukwang Pharmaceutical 43rd with KRW 1.2024, entering the top 50 with more than KRW 1 trillion in trading value.
GC Pharma and HanAll Biopharma joined the top 100 with more than KRW 500 billion in trading value.
Moreover, Kukje Pharma, United Pharmaceuticals, and Daewoong Pharmaceutical ranked in the top 150 with more than KRW 300 billion.
Pharmicell, Yuhan Corporation, Hanmi Pharmaceutical, Samsung Pharm., and Samil Pharmaceutical entered the top 200 with over KRW 200 billion, and 21 stocks, including Boryung Pharmaceutical, Il-Yang Pharmaceutical, and Chong Kun Dang Pharmaceutical, exceeded a monthly trading value of KRW 100 billion.
In terms of trading volume, Daewon Pharmaceutical ranked 28th with 98.29 million shares, and SK Bioscience placed 36th with 79.11 million shares, entering the top 50.
GeneOne Life Science ranked 54th with 58.29 million shares, Bukwang Pharmaceutical 55th with 56.93 million shares, Kukje Pharma 56th with 56.75 million shares, and Shinpoong Pharmaceutical 56th with 51.7 million shares.
Followed by these six stocks, Reyon Pharmaceutical, Samsung Pharm., Aprogen Pharmaceuticals, and HanAll Biopharma traded more than 20 million shares and ranked in the top 150.
In addition, Orient Bio, Pharmicell, Yungjin Pharmaceutical, Celltrion, and Myungmoon Pharm. entered in the top 200 with more than 10 million shares in trading volume.